The Tissue Resource Core of the Robert H. Lurie Comprehensive Cancer Center's Specialized Program of Research Excellence (SPORE) in breast cancer has two dedicated breast cancer treatment centers, Northwestern Memorial Hospital (NMH) and Evanston Northwestern Healthcare (ENH), dedicated to the collection, storage and distribution of human breast cancer for research. Because our institutions see large numbers of new breast cancer patients each year for surgical excision (>1100), our access to patient derived tissues for research is high (containing 12,000 archived cases and 450 fresh frozen samples to date), houses the national Pathology Coordinating Office (solid tumor tissue bank) for ECOG, and has participated with the UCSF and UNC SPORE programs as a sub- contracting institution. The NMH facility also has significant expertise in tumor banking through the Cancer Center's Research Histology/Tissue Procurement shared resource. This core will facilitate both the collection of fixed embedded and fresh frozen tissues as well as the acquisition and database storage of essential pathologic and clinical information needed for conducting translational research. This resource will benefit not only to the SPORE investigators, it will facilitate research activities of other scientists within and outside the parent institution. With time and accrual, we will be willing to participate in NCI-supported tissue networks so that the benefits of this resource are beyond our institution. This process will be supervised by a Tissue Review and Disbursement Committee, (including physicians and pathologists), and SPORE Executive Committee and reviews by the individual Institutional Review Boards (IRBs) on an annual basis.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
United States
Zip Code
Jordan, V Craig (2015) The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer. Endocr Relat Cancer 22:R1-31
Arora, Hans C; Jensen, Mark P; Yuan, Ye et al. (2012) Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells. Cancer Res 72:769-78
Wu, Aiguo; Paunesku, Tatjana; Zhang, Zhuoli et al. (2011) A Multimodal Nanocomposite for Biomedical Imaging. AIP Conf Proc 1365:379
Thurn, Kenneth T; Arora, Hans; Paunesku, Tatjana et al. (2011) Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine 7:123-30
Morrow, Monica; Chatterton Jr, Robert T; Rademaker, Alfred W et al. (2010) A prospective study of variability in mammographic density during the menstrual cycle. Breast Cancer Res Treat 121:565-74
Chatterton Jr, Robert Treat; Parker, Noah P; Habe-Evans, Mito et al. (2010) Breast ductal lavage for assessment of breast cancer biomarkers. Horm Cancer 1:197-204
Patel, Roshani R; Sengupta, Surojeet; Kim, Helen R et al. (2010) Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors. Eur J Cancer 46:1537-53
Balaburski, Gregor M; Dardes, Rita C; Johnson, Michael et al. (2010) Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol 37:387-98
Khan, Seema A; Lankes, Heather A; Patil, Deepa B et al. (2009) Ductal lavage is an inefficient method of biomarker measurement in high-risk women. Cancer Prev Res (Phila) 2:265-73
Jordan, V Craig; Lewis-Wambi, Joan S; Patel, Roshani R et al. (2009) New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast 18 Suppl 3:S10-7

Showing the most recent 10 out of 163 publications